Page last updated: 2024-08-23

ticrynafen and Adverse Drug Event

ticrynafen has been researched along with Adverse Drug Event in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (33.33)	18.7374
1990's	1 (16.67)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Riegelman, RK	1
Manns, MP; Straub, P; Van Pelt, FN	1
Wolfe, SM	1

Reviews

1 review(s) available for ticrynafen and Adverse Drug Event

Article	Year
Molecular basis of drug-induced immunological liver injury. Seminars in liver disease, 1995, Volume: 15, Issue:3 Topics: Animals; Antibody Formation; Anticonvulsants; Chemical and Drug Induced Liver Injury; Dihydralazine; Drug-Related Side Effects and Adverse Reactions; Halothane; Haptens; Humans; Liver; Liver Diseases; Ticrynafen	1995

Trials

1 trial(s) available for ticrynafen and Adverse Drug Event

Article	Year
What to do until the FDA arrives. Postgraduate medicine, 1981, Volume: 70, Issue:6 Topics: Chloramphenicol; Clinical Trials as Topic; Diethylstilbestrol; Drug and Narcotic Control; Drug Evaluation; Drug-Related Side Effects and Adverse Reactions; Humans; Influenza Vaccines; Risk; Ticrynafen; United States; United States Food and Drug Administration	1981

Other Studies

4 other study(ies) available for ticrynafen and Adverse Drug Event

Article	Year
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). PLoS computational biology, 2011, Volume: 7, Issue:12 Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests	2011
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
The marketing of a drug. Health & medicine : journal of the Health and Medicine Policy Research Group, 1982,Spring, Volume: 1, Issue:2 Topics: Chemical and Drug Induced Liver Injury; Drug Industry; Drug-Related Side Effects and Adverse Reactions; Humans; Hypertension; Jurisprudence; Product Surveillance, Postmarketing; Risk; Ticrynafen; United States; United States Food and Drug Administration	1982